Search

Search Results

• Effect of Immunoglobulin Therapy on the Rate of Infections in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation and or Treated with Immunomodulatory Agents

  Alhossain A. Khalafallah, Matthias Maiwald, Amanda Cox, Burns Denise, Gerald Bates, Terry Hannan, David Seaton, Bernadene Fernandopulle, Terry Brain

  e2010005

  2010-04-20

  https://doi.org/10.4084/mjhid.2010.005

  1210

  PDF: 588

  HTML: 1191

• PRELIMINARY STUDY OF SCD14 AND SCD163 AS PREDICTORS OF DISEASE SEVERITY AND ICU ADMISSION IN COVID-19: RELATION TO HEMATOLOGICAL PARAMETERS, BLOOD MORPHOLOGICAL CHANGES AND INFLAMMATORY BIOMARKERS

  hend Attia

  e2023046

  2023-08-29

  https://doi.org/10.4084/MJHID.2023.046

  1224

  PDF: 601

  HTML: 245

• DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA

  Ali Taher

  e2018066

  2018-11-01

  https://doi.org/10.4084/mjhid.2018.066

  3156

  PDF: 1653

  HTML: 366

• PREVALENCE OF THALASSEMIA IN THE VIETNAMESE POPULATION AND BUILDING A CLINICAL DECISION SUPPORT SYSTEM FOR PRENATAL SCREENING FOR THALASSEMIA

  Danh Cuong Tran, Anh Linh Dang, Thi Ngoc Lan Hoang, Chi Thanh Nguyen, Thi Ngoc Mai Dinh, Van Anh Tran, Thi Kim Phuong Doan, Thi Trang Nguyen

  e2023026

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.026

  4903

  HTML: 337

  PDF: 1380

• THALASSAEMIA INTERMEDIA : AN UPDATE

  Ali Taher, Khaled M. Musallam, Maria Domenica Cappellini

  e2009004

  2009-08-17

  1111

  PDF: 460

  HTML: 9471

• ROLE OF HEMATOLOGICAL PARAMETERS AS AN INDICATOR OF ACUTE MALARIAL INFECTION IN UTTARAKHAND STATE OF INDIA

  Smita Chandra, Harish Chandra

  e2013009

  2013-01-02

  https://doi.org/10.4084/mjhid.2013.009

  1853

  PDF: 831

  HTML: 5958

• A Suspected Case of Cerebral Fat Embolism Triggering a Drug-resistant Status Epilepticus in a HbS/β⁺-Thalassaemia Patient

  Marta Bortolotti, Gianluca Costamagna, Marta Mancarella, Delia Gagliardi, Silvia Lanfranconi, Alessia Marcon, Margherita Migone De Amicis, Nereo Bresolin, Stefania Corti, Giovanna Graziadei

  e2022019

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.019

  1056

  PDF: 592

  HTML: 270

• CARDIAC FUNCTION AND IRON CHELATION IN THALASSEMIA MAJOR AND INTERMEDIA: A REVIEW OF THE UNDERLYING PATHOPHYSIOLOGY AND APPROACH TO CHELATION MANAGEMENT

  Athanasios Aessopos, Vasilios Berdoukas

  e2009002

  2009-07-18

  1647

  PDF: 499

  HTML: 1564

• FINE MAPPING OF GLUCOSE 6 PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY IN RURAL AREA OF SOUTH WEST ODISHA USING THE CLINICAL, HEMATOLOGICAL AND MOLECULAR APPROACH

  Ravindra Kumar, MPSS Singh, Soumendu Mahapatra, Sonam Chourasia, Malay Kumar Tripathi, John Oommen, Praveen Kumar Bharti, Rajasubramaniam Shanmugam

  e2020015

  2020-02-26

  https://doi.org/10.4084/mjhid.2020.015

  2114

  PDF: 1066

  HTML: 645

• IRON CHELATION THERAPY WITH DEFERASIROX IN THE MANAGEMENT OF IRON OVERLOAD IN PRIMARY MYELOFIBROSIS

  Elena Maria Elli, Angelo Belotti, Andrea Aroldi, Matteo Parma, Pietro Pioltelli, Enrico Maria Pogliani

  e2014042

  2014-05-30

  https://doi.org/10.4084/mjhid.2014.042

  2214

  PDF: 1195

  HTML: 2017

• ASSOCİATİON BETWEEN IRON OVERLOAD AND GLUCOSE METABOLİSM İN CHİLDREN AND YOUTH WİTH TRANSFUSİON-DEPENDENT BETA THALASSEMİA: THE ROLE OF CHELATİON THERAPY

  Deniz Guven, Dr. İncefidan, Dr. Kazanci, Dr. Ozlem Kara

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.017

  758

  PDF: 689

  HTML: 143

• CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP

  Alessandro Laganà, Matteo Totaro, Maria Laura Bisegna, Loredana Elia, Stefania Intoppa, Marco Beldinanzi, Mabel Matarazzo, Mariangela di Trani, Alessandro Costa, Raffaele Maglione, Biancamaria Mandelli, Sabina Chiaretti, Maurizio Martelli, Maria Stefania De Propris

  e2024064

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.064

  1367

  PDF: 843

  Suppl. Files: 489

  Html: 117

• NG2 MOLECULE EXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA B CELLS: A FLOW-CYTOMETRIC MARKER FOR THE RAPID IDENTIFICATION OF KMT2A GENE REARRANGEMENTS

  Maria Laura Bisegna, Nadia Peragine, Loredana Elia, Mabel Matarazzo, Maria Laura Milani, Stefania Intoppa, Mariangela Di Trani, Francesco Malfona, Maurizio Martelli, Maria Stefania De Propris

  e2024018

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.018

  1056

  PDF: 1340

  Suppl. Files: 844

  HTML: 188

• Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma

  Valentina Giudice, Luca Pezzullo, Giuseppe Ciancia, Matteo D'Addona, Francesca D'Alto, Marisa Gorrese, Bianca Cuffa, Carmine Selleri

  e2022042

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.042

  952

  PDF: 454

  HTML: 210

• NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES

  Francesco D'Alò, Mariangela Greco, Marianna Criscuolo, Maria Teresa Voso

  e2010021

  2010-08-11

  https://doi.org/10.4084/mjhid.2010.021

  2083

  PDF: 1607

  HTML: 804

• A strange case of Malaria in a Nigerian native boy.

  Paola Magro, Ilaria Izzo, Barbara Saccani, Salvatore Casari, Silvio Caligaris, Lina Rachele Tomasoni, Alberto Matteelli, Annamaria Lombardi, Antonella Meini, Francesco Castelli

  e2017023

  2017-03-01

  https://doi.org/10.4084/mjhid.2017.023

  2505

  PDF: 897

  HTML: 1333

• PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES

  Stefano Lancellotti, Maria Basso, Raimondo De Cristofaro

  e2013058

  2013-09-01

  https://doi.org/10.4084/mjhid.2013.058

  3564

  PDF: 1203

  HTML: 24246

• EFFECTS OF THALIDOMIDE ON ENDOTHELIAL ACTIVATION AND STRESS INDEX IN CHILDREN WITH Β-THALASSEMIA MAJOR

  Kun Yang

  e2024076

  2024-10-31

  https://doi.org/10.4084/MJHID.2024.076

  1126

  PDF: 627

  HTML: 160

• DIAGNOSIS OF CONGENITAL CYTOMEGALOVIRUS INFECTION IN HIGH RISK NEONATES

  Ehab abdelmoniem Albanna, Randa Saddek Abd El-latif, Hend Alsayed Sharaf, Maha Kamal Gohar, Basem Mohamed Ibrahim

  e2013049

  2013-07-10

  https://doi.org/10.4084/mjhid.2013.049

  2133

  PDF: 1018

  HTML: 2351

• MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY

  Emanuele Angelucci, Silvana Anna Maria Urru, Federica Pilo, Alberto Piperno

  e2017021

  2017-03-01

  https://doi.org/10.4084/mjhid.2017.021

  3771

  PDF: 1338

  HTML: 2167

  Fig.1: 236

  Fig. 2: 230

• PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS

  Mario Sabatelli, Luca Laurenti, Marco Luigetti

  e2018057

  2018-09-01

  https://doi.org/10.4084/mjhid.2018.057

  1843

  PDF: 909

  HTML: 457

  Fig1: 259

  Fig.2: 274

  Fig. 3: 214

  Fig. 5: 226

  Fig. 4: 251

• DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS

  Annemarie Van de Vyver, Adele Visser

  e2010032

  2010-11-10

  https://doi.org/10.4084/mjhid.2010.032

  1352

  PDF: 910

  HTML: 1199

  Coverletter: 236

• PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.

  Ariel Koren, Lora Profeta, Luci Zalman, Haya Palmor, Carina Levin, Ronit Bril Zamir, Stavit Shalev, Orna Blondheim

  e2014012

  2014-02-17

  https://doi.org/10.4084/mjhid.2014.012

  3189

  PDF: 1306

  HTML: 11860

• PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis

  Fiorina Giona

  e2021069

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.069

  1955

  HTML: 1655

  PDF: 1153

• HbD Punjab/HbQ India compound heterozygosity: An unusual association.

  Stacy Colaco, Reema Surve, Pratibha Sawant, Anita Nadkarni, Kanjaksha Ghosh, Roshan Colah

  e2014072

  2014-11-01

  https://doi.org/10.4084/mjhid.2014.072

  1598

  PDF: 840

  HTML: 5614

• Seven-Year Course of Hypoplastic Myelodysplastic Syndrome Unmasked by Secondary and Neurosyphilis.

  Ali Turunç, Hüseyin Derya Dinçyürek, Birol Güvenç

  e2026026

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.026

  574

  PDF: 393

  HTML: 220

• EVALUATION OF GLUTATHIONE-S-TRANSFERASE P1 POLYMORPHISM AND ITS RELATION TO BONE MINERAL DENSITY IN EGYPTIAN CHILDREN AND ADOLESCENTS WITH BETA- THALASSEMIA MAJOR

  Seham Ragab

  e2016004

  2016-01-01

  https://doi.org/10.4084/mjhid.2016.004

  3977

  PDF: 889

  HTML: 2470

  Figures: 193

• Bortezomib a safety treatment for patients with Multiple Myeloma and Cystic Fibrosis

  Fabiana Gentilini, Anna Levi, Vincenzo Federico, Eleonora Russo, Robin Foà, Maria Teresa Petrucci

  e2012035

  2012-05-07

  https://doi.org/10.4084/mjhid.2012.035

  1659

  PDF: 785

  HTML: 662